Endometriosis Treatment Market
Market Insights on Endometriosis Treatment covering sales outlook, demand forecast & up-to-date key trends
Endometriosis Treatment Market By Drug (Oral Contraceptives, Progestins, NSAIDs, GnRH Analogues, LNR-IUDs), Treatment Type (Hormonal Therapy, Pain Management), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drugstores, e-Commerce) & Region - Forecast 2019 - 2030
Oral Contraceptive Drugs Capture Around 50% Value Share
Oral contraceptives are highly preferable as a first-line treatment for patients without contraindications, on grounds of their efficacy in preventing recurrence of pelvic pain and endometriosis lesions. However, they are associated with possible side effects such as mood changes, nausea, and elevated blood pressure levels. Progestins, on the other hand, require to be consumed periodically, unlike oral contraceptives, which require regular consumption.
By 2029, the drug category will represent a billion-dollar opportunity. Furthermore, market players are unlocking new revenue streams in gonadotropin-releasing hormone (GnRH) analogues for relevant value creation.
Let us know your requirement to get
100% FREE customization
Opportunities Prevail in Developed Regions
Europe and North America will maintain their supremacy in the global endometriosis treatment market, with the latter expected to cross US$ 1 Bn in 2020. Incumbents are pairing with healthcare providers to raise awareness in the field of endometriosis at physician and patient levels.
While these developed regional markets maintain a positive trend, stakeholders are eyeing Asia for further revenue lines. Governments in China and India are significantly increasing their healthcare budgets in order to reach the unmet sections of society.
Advanced Drug Delivery Technologies to Propel Market Growth
Oral contraceptives have been the conventional drug category for treating endometriosis. Yet, they carry the drawback of first-pass liver metabolism. Market players are rolling out novel transdermal drug delivery technologies such as topical applicators to enhance efficacy and overcome the disadvantages of oral contraceptives.
Moreover, these advanced drug delivery technologies achieve steady serum hormone concentration, and thus, are expected to become commonplace in endometriosis treatment. For instance, Noven has developed CombiPatch®, a combination (two-drug) patch that can be effectively used in endometriosis treatment.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystHow Growth will Unfold
Market player continue to bank on hormonal therapy to stay ahead of their peers in the endometriosis treatment market. FMI finds that, around 9 out of 10 medical professionals prefer hormonal replacement therapy for treating endometriosis, attributable to its enhanced effectiveness with minimum risks of breast cancer.
That being said, patients undergoing the treatment are subject to post-therapy complications such as bloating, indigestion, and leg cramps. As such, they are turning to other options, including pain management.
Market segmentation
The global endometriosis treatment market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.
Drug:
- Oral Contraceptives
- Progestins
- NSAIDs
- GnRH Analogues
- LNR-IUDs
- Others
Treatment Type:
- Hormonal Therapy
- Pain Management
Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Drugstores
- e-Commerce
Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa (MEA)
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Frequently Asked Questions
The endometriosis treatment market is likely to secure a CAGR of 10.6% through 2032.
The endometriosis treatment market size is estimated to cross US$ 3.55 Billion by 2032.
The endometriosis treatment market is likely to record a value of US$ 1.30 Billion in 2022.
Europe is likely to lead the endometriosis treatment market.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Drug Development Trends
4. Key Success Factors
4.1. Product Adoption / Usage Analysis
4.2. Endometriosis Epidemiology, By Key Region
4.3. Unmet Needs of Endometriosis Treatment
4.3.1. Potential Diagnostic Biomarkers for Endometriosis
4.3.1.1. Existing & Emerging Non-invasive Diagnostics Techniques
4.3.2. Disease Awareness and Educational Strategies for Medical Professionals
4.3.3. Drug Effectivity & Safety, By Drug
4.3.4. Marketed & Emerging Non-hormonal Therapies for Endometriosis
4.3.5. Disease Etiology and Pathophysiology
4.4. Research and Development Strategies
4.4.1. Reformulations and Label Expansion of Currently Marketed Drugs
4.4.2. Pipeline Assessment of GnRH Antagonists
4.4.3. Pipeline Assessment of Novel Non-hormonal Therapies
4.4.4. Key Strategies Followed By Manufacturers (Alliance, In-Licensing and Out-Licensing Strategies)
4.4.5. Strategy to Maximise Return on Investment (Drug Approvals for Secondary Indication)
4.5. Attributes/Factors Important in Clinical Trials
4.6. Clinical Trial History of Key Marketed Drugs
4.7. Attributes/Factors considered for Market Sizing of Historical Market Sizing & Opportunity Assessment of Pipeline Drugs
4.8. Pipeline Assessment/Clinical Benchmark Analysis
4.8.1. Marketed Drug/Pipeline Valuation Analysis
4.8.1.1. Therapeutic Advantages by Drug
4.8.1.2. New Drug Launches and Regulatory Approvals, 2019-2030
4.8.1.3. Opportunity Assessment in terms of Revenue, 2020-2025
4.8.1.4. Clinical Trials and Pipeline Overview
4.9. Regulatory Scenario
4.10. Reimbursement Scenario
4.11. Primary Verbatim, Key Opinion Leaders Opinion on Future Opportunities
5. Global Endometriosis Treatment Market Demand (Size in US$ Mn) Analysis 2014-2018 and Opportunity Assessment, 2019-2030
5.1. Historical Market Value (US$ Mn) Analysis, 2014-2018
5.2. Current and Future Market Value (US$ Mn) Projections, 2019-2030
5.2.1. Y-o-Y Growth Trend Analysis
5.2.2. Absolute $ Opportunity Analysis
6. Market Background
6.1. Macro-Economic Factors
6.1.1. Global GDP Growth Outlook
6.1.2. Global Healthcare Outlook
6.1.3. Per Capita Healthcare Expenditure Outlook
6.2. Opportunity Assessment Factors - Relevance & Impact
6.2.1. Prevalence of Endometriosis
6.2.2. Growing Healthcare Expenditure
6.2.3. Increasing Number of Clinical Trials
6.2.4. Regulatory Policy Changes
6.3. Market Dynamics
6.3.1. Drivers
6.3.2. Restraints
6.3.3. Opportunity Analysis
7. Global Endometriosis Treatment Market Analysis 2014-2018 and Opportunity Assessment 2019-2030, by Drug
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Mn) Analysis By Drug, 2014-2018
7.3. Current and Future Market Size (US$ Mn) Analysis and Opportunity Assessment By Drug, 2019-2030
7.3.1. Oral Contraceptives
7.3.2. Progestins
7.3.3. NSAIDs
7.3.4. GnRH Analogues
7.3.5. LNR-IUDs
7.3.6. Others
7.4. Market Attractiveness Analysis By Drug
8. Global Endometriosis Treatment Market Analysis 2014-2018 and Opportunity Assessment 2019-2030, by Treatment Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Treatment Type, 2014-2018
8.3. Current and Future Market Size (US$ Mn) Analysis and Opportunity Assessment By Treatment Type, 2019-2030
8.3.1. Hormonal Therapy
8.3.2. Pain management
8.4. Market Attractiveness Analysis By Treatment Type
9. Global Endometriosis Treatment Market Analysis 2014-2018 and Opportunity Assessment 2019-2030, by Distribution Channel
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2014-2018
9.3. Current and Future Market Size (US$ Mn) Analysis and Opportunity Assessment By Distribution Channel, 2019-2030
9.3.1. Hospital Pharmacies
9.3.2. Retail Pharmacies
9.3.3. Drugstores
9.3.4. E-commerce
9.4. Market Attractiveness Analysis By Distribution Channel
10. Global Endometriosis Treatment Market Analysis 2014-2018 and Opportunity Assessment 2019-2030, by Region
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Region, 2014-2018
10.3. Current and Future Market Size (US$ Mn) Analysis and Opportunity Assessment By Region, 2019-2030
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. East Asia
10.3.5. South Asia
10.3.6. Oceania
10.3.7. Middle East and Africa (MEA)
10.4. Market Attractiveness Analysis By Region
11. North America Endometriosis Treatment Market Analysis 2014-2018 and Opportunity Assessment 2019-2030
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2018
11.3. Current and Future Market Size (US$ Mn) Analysis and Opportunity Assessment By Market Taxonomy, 2019-2030
11.3.1. By Country
11.3.1.1. U.S.
11.3.1.2. Canada
11.3.2. By Drug
11.3.3. By Treatment Type
11.3.4. By Distribution Channel
11.4. Market Attractiveness Analysis
11.4.1. By Country
11.4.2. By Drug
11.4.3. By Treatment Type
11.4.4. By Distribution Channel
11.5. Key Market Participants - Intensity Mapping
11.6. Drivers and Restraints - Impact Analysis
12. Latin America Endometriosis Treatment Market Analysis 2014-2018 and Opportunity Assessment 2019-2030
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2018
12.3. Current and Future Market Size (US$ Mn) Analysis and Opportunity Assessment By Market Taxonomy, 2019-2030
12.3.1. By Country
12.3.1.1. Brazil
12.3.1.2. Mexico
12.3.1.3. Argentina
12.3.1.4. Rest of Latin America
12.3.2. By Drug
12.3.3. By Treatment Type
12.3.4. By Distribution Channel
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Drug
12.4.3. By Treatment Type
12.4.4. By Distribution Channel
12.5. Key Market Participants - Intensity Mapping
12.6. Drivers and Restraints - Impact Analysis
13. Europe Endometriosis Treatment Market Analysis 2014-2018 and Opportunity Assessment 2019-2030
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2018
13.3. Current and Future Market Size (US$ Mn) Analysis and Opportunity Assessment By Market Taxonomy, 2019-2030
13.3.1. By Country
13.3.1.1. Germany
13.3.1.2. Italy
13.3.1.3. France
13.3.1.4. U.K.
13.3.1.5. Spain
13.3.1.6. BENELUX
13.3.1.7. Russia
13.3.1.8. Rest of Europe
13.3.2. By Drug
13.3.3. By Treatment Type
13.3.4. By Distribution Channel
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Drug
13.4.3. By Treatment Type
13.4.4. By Distribution Channel
13.5. Key Market Participants - Intensity Mapping
13.6. Drivers and Restraints - Impact Analysis
14. South Asia Endometriosis Treatment Market Analysis 2014-2018 and Opportunity Assessment 2019-2030
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2018
14.3. Current and Future Market Size (US$ Mn) Analysis and Opportunity Assessment By Market Taxonomy, 2019-2030
14.3.1. By Country
14.3.1.1. India
14.3.1.2. Thailand
14.3.1.3. Indonesia
14.3.1.4. Malaysia
14.3.1.5. Rest of South Asia
14.3.2. By Drug
14.3.3. By Treatment Type
14.3.4. By Distribution Channel
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Drug
14.4.3. By Treatment Type
14.4.4. By Distribution Channel
14.5. Key Market Participants - Intensity Mapping
14.6. Drivers and Restraints - Impact Analysis
15. East Asia Endometriosis Treatment Market Analysis 2014-2018 and Opportunity Assessment 2019-2030
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2018
15.3. Current and Future Market Size (US$ Mn) Analysis and Opportunity Assessment By Market Taxonomy, 2019-2030
15.3.1. By Country
15.3.1.1. China
15.3.1.2. Japan
15.3.1.3. South Korea
15.3.2. By Drug
15.3.3. By Treatment Type
15.3.4. By Distribution Channel
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Drug
15.4.3. By Treatment Type
15.4.4. By Distribution Channel
15.5. Key Market Participants - Intensity Mapping
15.6. Drivers and Restraints - Impact Analysis
16. Oceania Endometriosis Treatment Market Analysis 2014-2018 and Opportunity Assessment 2019-2030
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2018
16.3. Current and Future Market Size (US$ Mn) Analysis and Opportunity Assessment By Market Taxonomy, 2019-2030
16.3.1. By Country
16.3.1.1. Australia
16.3.1.2. New Zealand
16.3.2. By Drug
16.3.3. By Treatment Type
16.3.4. By Distribution Channel
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Drug
16.4.3. By Treatment Type
16.4.4. By Distribution Channel
16.5. Key Market Participants - Intensity Mapping
16.6. Drivers and Restraints - Impact Analysis
17. Middle East and Africa Endometriosis Treatment Market Analysis 2014-2018 and Opportunity Assessment 2019-2030
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2018
17.3. Current and Future Market Size (US$ Mn) Analysis and Opportunity Assessment By Market Taxonomy, 2019-2030
17.3.1. By Country
17.3.1.1. GCC Countries
17.3.1.2. Turkey
17.3.1.3. Northern Africa
17.3.1.4. South Africa
17.3.1.5. Rest of Middle East and Africa
17.3.2. By Drug
17.3.3. By Treatment Type
17.3.4. By Distribution Channel
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Drug
17.4.3. By Treatment Type
17.4.4. By Distribution Channel
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis
18. Emerging Countries Endometriosis Treatment Market Analysis 2014-2018 and Opportunity Assessment 2019-2030
18.1. Introduction
18.1.1. Market Value Proportion Analysis, By Key Countries
18.1.2. Global Vs. Country Growth Comparison
18.2. India Endometriosis Treatment Market Analysis
18.2.1. Introduction
18.2.2. PEST Analysis
18.2.3. Market Value Analysis by Market Taxonomy
18.2.4. Market Value (US$ Mn) Analysis and Opportunity Assessment by Market Taxonomy
18.2.4.1. By Drug
18.2.4.2. By Treatment Type
18.2.4.3. By Distribution Channel
18.3. China Endometriosis Treatment Market Analysis
18.3.1. Introduction
18.3.2. PEST Analysis
18.3.3. Market Value Analysis by Market Taxonomy
18.3.4. Market Value (US$ Mn) Analysis and Opportunity Assessment by Market Taxonomy
18.3.4.1. Drug
18.3.4.2. By Treatment Type
18.3.4.3. By Distribution Channel
18.4. Brazil Endometriosis Treatment Market Analysis
18.4.1. Introduction
18.4.2. PEST Analysis
18.4.3. Market Value Analysis by Market Taxonomy
18.4.4. Market Value (US$ Mn) Analysis and Opportunity Assessment by Market Taxonomy
18.4.4.1. By Drug
18.4.4.2. By Treatment Type
18.4.4.3. By Distribution Channel
19. U.S. Endometriosis Treatment Market Analysis 2014-2018 and Opportunity Assessment 2019-2030
19.1. Introduction
19.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2018
19.3. Current and Future Market Size (US$ Mn) Analysis and Opportunity Assessment By Market Taxonomy, 2019-2030
19.3.1. By Drug
19.3.2. By Treatment Type
19.3.3. By Distribution Channel
19.4. Market Attractiveness Analysis
20. Canada Endometriosis Treatment Market Analysis 2014-2018 and Opportunity Assessment 2019-2030
20.1. Introduction
20.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2018
20.3. Current and Future Market Size (US$ Mn) Analysis and Opportunity Assessment By Market Taxonomy, 2019-2030
20.3.1. By Drug
20.3.2. By Treatment Type
20.3.3. By Distribution Channel
20.4. Market Attractiveness Analysis
21. Mexico Endometriosis Treatment Market Analysis 2014-2018 and Opportunity Assessment 2019-2030
21.1. Introduction
21.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2018
21.3. Current and Future Market Size (US$ Mn) Analysis and Opportunity Assessment By Market Taxonomy, 2019-2030
21.3.1. By Drug
21.3.2. By Treatment Type
21.3.3. By Distribution Channel
21.4. Market Attractiveness Analysis
22. Germany Endometriosis Treatment Market Analysis 2014-2018 and Opportunity Assessment 2019-2030
22.1. Introduction
22.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2018
22.3. Current and Future Market Size (US$ Mn) Analysis and Opportunity Assessment By Market Taxonomy, 2019-2030
22.3.1. By Drug
22.3.2. By Treatment Type
22.3.3. By Distribution Channel
22.4. Market Attractiveness Analysis
23. U.K. Endometriosis Treatment Market Analysis 2014-2018 and Opportunity Assessment 2019-2030
23.1. Introduction
23.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2018
23.3. Current and Future Market Size (US$ Mn) Analysis and Opportunity Assessment By Market Taxonomy, 2019-2030
23.3.1. By Drug
23.3.2. By Treatment Type
23.3.3. By Distribution Channel
23.4. Market Attractiveness Analysis
24. France Endometriosis Treatment Market Analysis 2014-2018 and Opportunity Assessment 2019-2030
24.1. Introduction
24.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2018
24.3. Current and Future Market Size (US$ Mn) Analysis and Opportunity Assessment By Market Taxonomy, 2019-2030
24.3.1. By Drug
24.3.2. By Treatment Type
24.3.3. By Distribution Channel
24.4. Market Attractiveness Analysis
25. Italy Endometriosis Treatment Market Analysis 2014-2018 and Opportunity Assessment 2019-2030
25.1. Introduction
25.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2018
25.3. Current and Future Market Size (US$ Mn) Analysis and Opportunity Assessment By Market Taxonomy, 2019-2030
25.3.1. By Drug
25.3.2. By Treatment Type
25.3.3. By Distribution Channel
25.4. Market Attractiveness Analysis
26. Spain Endometriosis Treatment Market Analysis 2014-2018 and Opportunity Assessment 2019-2030
26.1. Introduction
26.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2018
26.3. Current and Future Market Size (US$ Mn) Analysis and Opportunity Assessment By Market Taxonomy, 2019-2030
26.3.1. By Drug
26.3.2. By Treatment Type
26.3.3. By Distribution Channel
26.4. Market Attractiveness Analysis
27. Russia Endometriosis Treatment Market Analysis 2014-2018 and Opportunity Assessment 2019-2030
27.1. Introduction
27.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2018
27.3. Current and Future Market Size (US$ Mn) Analysis and Opportunity Assessment By Market Taxonomy, 2019-2030
27.3.1. By Drug
27.3.2. By Treatment Type
27.3.3. By Distribution Channel
27.4. Market Attractiveness Analysis
27.5. Market Attractiveness Analysis
28. Japan Endometriosis Treatment Market Analysis 2014-2018 and Opportunity Assessment 2019-2030
28.1. Introduction
28.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2018
28.3. Current and Future Market Size (US$ Mn) Analysis and Opportunity Assessment By Market Taxonomy, 2019-2030
28.3.1. By Drug
28.3.2. By Treatment Type
28.3.3. By Distribution Channel
28.4. Market Attractiveness Analysis
29. South Korea Endometriosis Treatment Market Analysis 2014-2018 and Opportunity Assessment 2019-2030
29.1. Introduction
29.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2018
29.3. Current and Future Market Size (US$ Mn) Analysis and Opportunity Assessment By Market Taxonomy, 2019-2030
29.3.1. By Drug
29.3.2. By Treatment Type
29.3.3. By Distribution Channel
29.4. Market Attractiveness Analysis
30. Australia Endometriosis Treatment Market Analysis 2014-2018 and Opportunity Assessment 2019-2030
30.1. Introduction
30.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2018
30.3. Current and Future Market Size (US$ Mn) Analysis and Opportunity Assessment By Market Taxonomy, 2019-2030
30.3.1. By Drug
30.3.2. By Treatment Type
30.3.3. By Distribution Channel
30.4. Market Attractiveness Analysis
31. New Zealand Endometriosis Treatment Market Analysis 2014-2018 and Opportunity Assessment 2019-2030
31.1. Introduction
31.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2018
31.3. Current and Future Market Size (US$ Mn) Analysis and Opportunity Assessment By Market Taxonomy, 2019-2030
31.3.1. By Drug
31.3.2. By Treatment Type
31.3.3. By Distribution Channel
31.4. Market Attractiveness Analysis
32. GCC Countries Endometriosis Treatment Market Analysis 2014-2018 and Opportunity Assessment 2019-2030
32.1. Introduction
32.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2018
32.3. Current and Future Market Size (US$ Mn) Analysis and Opportunity Assessment By Market Taxonomy, 2019-2030
32.3.1. By Drug
32.3.2. By Treatment Type
32.3.3. By Distribution Channel
32.4. Market Attractiveness Analysis
33. South Africa Endometriosis Treatment Market Analysis 2014-2018 and Opportunity Assessment 2019-2030
33.1. Introduction
33.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2018
33.3. Current and Future Market Size (US$ Mn) Analysis and Opportunity Assessment By Market Taxonomy, 2019-2030
33.3.1. By Drug
33.3.2. By Treatment Type
33.3.3. By Distribution Channel
33.4. Market Attractiveness Analysis
34. Market Structure Analysis
34.1. Market Analysis by Tier of Companies
34.2. Market Share Analysis of Top Players
34.3. Company Share Analysis
34.4. Market Presence Analysis
34.4.1. By Regional footprint of Players
34.4.2. Channel Foot Print by Players
35. Competition Analysis
35.1. Competition Dashboard
35.2. Competition Benchmarking
35.3. Competition Deep Dive (Tentative List)
35.3.1. AbbVie Inc.
35.3.1.1. Overview
35.3.1.2. Service Portfolio
35.3.1.3. Profitability by Market Segments (Service/Channel/Region)
35.3.1.4. Sales Footprint
35.3.1.5. Strategy Overview
35.3.1.5.1. Marketing Strategy
35.3.1.5.2. Service Strategy
35.3.1.5.3. Channel Strategy
35.3.2. Bayer AG
35.3.2.1. Overview
35.3.2.2. Service Portfolio
35.3.2.3. Profitability by Market Segments (Service/Channel/Region)
35.3.2.4. Sales Footprint
35.3.2.5. Strategy Overview
35.3.2.5.1. Marketing Strategy
35.3.2.5.2. Service Strategy
35.3.2.5.3. Channel Strategy
35.3.3. AstraZeneca
35.3.3.1. Overview
35.3.3.2. Service Portfolio
35.3.3.3. Profitability by Market Segments (Service/Channel/Region)
35.3.3.4. Sales Footprint
35.3.3.5. Strategy Overview
35.3.3.5.1. Marketing Strategy
35.3.3.5.2. Service Strategy
35.3.3.5.3. Channel Strategy
35.3.4. Pfizer Inc.
35.3.4.1. Overview
35.3.4.2. Service Portfolio
35.3.4.3. Profitability by Market Segments (Service/Channel/Region)
35.3.4.4. Sales Footprint
35.3.4.5. Strategy Overview
35.3.4.5.1. Marketing Strategy
35.3.4.5.2. Service Strategy
35.3.4.5.3. Channel Strategy
35.3.5. Teva Pharmaceutical Industries Ltd.
35.3.5.1. Overview
35.3.5.2. Service Portfolio
35.3.5.3. Profitability by Market Segments (Service/Channel/Region)
35.3.5.4. Sales Footprint
35.3.5.5. Strategy Overview
35.3.5.5.1. Marketing Strategy
35.3.5.5.2. Service Strategy
35.3.5.5.3. Channel Strategy
35.3.6. Ipsen Pharma
35.3.6.1. Overview
35.3.6.2. Service Portfolio
35.3.6.3. Profitability by Market Segments (Service/Channel/Region)
35.3.6.4. Sales Footprint
35.3.6.5. Strategy Overview
35.3.6.5.1. Marketing Strategy
35.3.6.5.2. Service Strategy
35.3.6.5.3. Channel Strategy
35.3.7. Myovant Sciences
35.3.7.1. Overview
35.3.7.2. Service Portfolio
35.3.7.3. Profitability by Market Segments (Service/Channel/Region)
35.3.7.4. Sales Footprint
35.3.7.5. Strategy Overview
35.3.7.5.1. Marketing Strategy
35.3.7.5.2. Service Strategy
35.3.7.5.3. Channel Strategy
35.3.8. Endoceutics, Inc.
35.3.8.1. Overview
35.3.8.2. Service Portfolio
35.3.8.3. Profitability by Market Segments (Service/Channel/Region)
35.3.8.4. Sales Footprint
35.3.8.5. Strategy Overview
35.3.8.5.1. Marketing Strategy
35.3.8.5.2. Service Strategy
35.3.8.5.3. Channel Strategy
35.3.9. Debiopharm Group
35.3.9.1. Overview
35.3.9.2. Service Portfolio
35.3.9.3. Profitability by Market Segments (Service/Channel/Region)
35.3.9.4. Sales Footprint
35.3.9.5. Strategy Overview
35.3.9.5.1. Marketing Strategy
35.3.9.5.2. Service Strategy
35.3.9.5.3. Channel Strategy
35.3.10. Mayne Pharma Group Limited
35.3.10.1. Overview
35.3.10.2. Service Portfolio
35.3.10.3. Profitability by Market Segments (Service/Channel/Region)
35.3.10.4. Sales Footprint
35.3.10.5. Strategy Overview
35.3.10.5.1. Marketing Strategy
35.3.10.5.2. Service Strategy
35.3.10.5.3. Channel Strategy
35.3.11. Noven Pharmaceuticals, Inc.
35.3.11.1. Overview
35.3.11.2. Service Portfolio
35.3.11.3. Profitability by Market Segments (Service/Channel/Region)
35.3.11.4. Sales Footprint
35.3.11.5. Strategy Overview
35.3.11.5.1. Marketing Strategy
35.3.11.5.2. Service Strategy
35.3.11.5.3. Channel Strategy
35.3.12. Sun Pharmaceutical Industries Limited
35.3.12.1. Overview
35.3.12.2. Service Portfolio
35.3.12.3. Profitability by Market Segments (Service/Channel/Region)
35.3.12.4. Sales Footprint
35.3.12.5. Strategy Overview
35.3.12.5.1. Marketing Strategy
35.3.12.5.2. Service Strategy
35.3.12.5.3. Channel Strategy
35.3.13. Amneal Pharmaceuticals, Inc. Endometriosis Treatment Market_Global Industry Analysis 2014-2018 and Opportunity Assessment 2019-2030
35.3.13.1. Overview
35.3.13.2. Service Portfolio
35.3.13.3. Profitability by Market Segments (Service/Channel/Region)
35.3.13.4. Sales Footprint
35.3.13.5. Strategy Overview
35.3.13.5.1. Marketing Strategy
35.3.13.5.2. Service Strategy
35.3.13.5.3. Channel Strategy
35.3.14. Mylan N.V.
35.3.14.1. Overview
35.3.14.2. Service Portfolio
35.3.14.3. Profitability by Market Segments (Service/Channel/Region)
35.3.14.4. Sales Footprint
35.3.14.5. Strategy Overview
35.3.14.5.1. Marketing Strategy
35.3.14.5.2. Service Strategy
35.3.14.5.3. Channel Strategy
35.3.15. Aurobindo Pharma
35.3.15.1. Overview
35.3.15.2. Service Portfolio
35.3.15.3. Profitability by Market Segments (Service/Channel/Region)
35.3.15.4. Sales Footprint
35.3.15.5. Strategy Overview
35.3.15.5.1. Marketing Strategy
35.3.15.5.2. Service Strategy
35.3.15.5.3. Channel Strategy
36. Assumptions and Acronyms Used
37. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables:
Table 01: Global Endometriosis Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2014-2030, By Drug
Table 02: Global Endometriosis Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2014-2030, By Treatment Type
Table 03: Global Endometriosis Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2014-2030, By Distribution Channel
Table 04: Global Endometriosis Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2014-2030, By Region
Table 05: North America Endometriosis Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2030, By Country
Table 06: North America Endometriosis Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2030, By Drug
Table 07: North America Endometriosis Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2030, By Treatment Type
Table 08: North America Endometriosis Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2030, By Distribution Channel
Table 09: Latin America Endometriosis Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2030, By Country
Table 10: Latin America Endometriosis Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2030, By Drug
Table 11: Latin America Endometriosis Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2030, By Treatment Type
Table 12: Latin America Endometriosis Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2030, By Distribution Channel
Table 13: Europe Endometriosis Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2030, By Country
Table 14: Europe Endometriosis Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2030, By Drug
Table 15: Europe Endometriosis Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2030, By Treatment Type
Table 16: Europe Endometriosis Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2030, By Distribution Channel
Table 17: South Asia Endometriosis Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2030, By Country
Table 18: South Asia Endometriosis Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2030, By Drug
Table 19: South Asia Endometriosis Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2030, By Treatment Type
Table 20: South Asia Endometriosis Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2030, By Distribution Channel
Table 21: East Asia Endometriosis Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2030, By Country
Table 22: East Asia Endometriosis Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2030, By Drug
Table 23: East Asia Endometriosis Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2030, By Treatment Type
Table 24: East Asia Endometriosis Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2030, By Distribution Channel
Table 25: Oceania Endometriosis Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2030, By Country
Table 26: Oceania Endometriosis Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2030, By Drug
Table 27: Oceania Endometriosis Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2030, By Treatment Type
Table 28: Oceania Endometriosis Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2030, By Distribution Channel
Table 29: MEA Endometriosis Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2030, By Country
Table 30: MEA Endometriosis Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2030, By Drug
Table 31: MEA Endometriosis Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2030, By Treatment Type
Table 32: MEA Endometriosis Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2030, By Distribution Channel
Table 33: India Endometriosis Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2030, By Drug
Table 34: India Endometriosis Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2030, By Treatment Type
Table 35: India Endometriosis Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2030, By Distribution Channels
Table 36: China Endometriosis Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2030, By Drug
Table 37: China Endometriosis Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2030, By Treatment Type
Table 38: China Endometriosis Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2030, By Distribution Channels
Table 39: Brazil Endometriosis Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2030, By Drug
Table 40: Brazil Endometriosis Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2030, By Treatment Type
Table 41: Brazil Endometriosis Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2030, By Distribution Channels
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Figures:
Figure 01: Global Endometriosis Treatment Market Value Analysis (US$ Mn), 2014-2018
Figure 02: Global Endometriosis Treatment Market Value Forecast (US$ Mn), 2019-2030
Figure 03: Global Endometriosis Treatment Market Absolute $ Opportunity, 2019 - 2030
Figure 04: Global Endometriosis Treatment Market Share Analysis (%), By Drug, 2019-2030
Figure 05: Global Endometriosis Treatment Market Y-o-Y Analysis (%), By Drug, 2019-2030
Figure 06: Global Endometriosis Treatment Market Attractiveness Analysis by Drug, 2019-2030
Figure 07: Global Endometriosis Treatment Market Share Analysis (%), By Treatment Type, 2019-2030
Figure 08: Global Endometriosis Treatment Market Y-o-Y Analysis (%), By Treatment Type, 2019-2030
Figure 09: Global Endometriosis Treatment Market Attractiveness Analysis by Treatment Type, 2019-2030
Figure 10: Global Endometriosis Treatment Market Share Analysis (%), By Distribution Channel, 2019-2030
Figure 11: Global Endometriosis Treatment Market Y-o-Y Analysis (%), By Distribution Channel, 2019-2030
Figure 12: Global Endometriosis Treatment Market Attractiveness Analysis by Distribution Channel, 2019-2030
Figure 13: Global Endometriosis Treatment Market Share Analysis (%), By Region, 2019-2030
Figure 14: Global Endometriosis Treatment Market Y-o-Y Analysis (%), By Region, 2019-2030
Figure 15: Global Endometriosis Treatment Market Attractiveness Analysis by Region, 2019-2030
Figure 16: North America Endometriosis Treatment Market Value Share, By Drug, 2019 (E)
Figure 17: North America Endometriosis Treatment Market Value Share, By Treatment Type, 2019 (E)
Figure 18: North America Endometriosis Treatment Market Value Share, By Distribution Channel, 2019 (E)
Figure 19: North America Endometriosis Treatment Market Value Share, By Country, 2019 (E)
Figure 20: North America Endometriosis Treatment Market Value Analysis (US$ Mn), 2014-2018
Figure 21: North America Endometriosis Treatment Market Value Forecast (US$ Mn), 2019-2030
Figure 22: North America Endometriosis Treatment Market Attractiveness Analysis by Drug, 2019-2030
Figure 23: North America Endometriosis Treatment Market Attractiveness Analysis by Treatment Type, 2019-2030
Figure 24: North America Endometriosis Treatment Market Attractiveness Analysis by Distribution Channels, 2019-2030
Figure 25: North America Endometriosis Treatment Market Attractiveness Analysis by Country, 2019-2030
Figure 26: Latin America Endometriosis Treatment Market Value Share, By Drug, 2019 (E)
Figure 27: Latin America Endometriosis Treatment Market Value Share, By Treatment Type, 2019 (E)
Figure 28: Latin America Endometriosis Treatment Market Value Share, By Distribution Channel, 2019 (E)
Figure 29: Latin America Endometriosis Treatment Market Value Share, By Country, 2019 (E)
Figure 30: Latin America Endometriosis Treatment Market Value Analysis (US$ Mn), 2014-2018
Figure 31: Latin America Endometriosis Treatment Market Value Forecast (US$ Mn), 2019-2030
Figure 32: Latin America Endometriosis Treatment Market Attractiveness Analysis by Drug, 2019-2030
Figure 33: Latin America Endometriosis Treatment Market Attractiveness Analysis by Treatment Type, 2019-2030
Figure 34: Latin America Endometriosis Treatment Market Attractiveness Analysis by Distribution Channels, 2019-2030
Figure 35: Latin America Endometriosis Treatment Market Attractiveness Analysis by Country, 2019-2030
Figure 36: Europe Endometriosis Treatment Market Value Share, By Drug, 2019 (E)
Figure 37: Europe Endometriosis Treatment Market Value Share, By Treatment Type, 2019 (E)
Figure 38: Europe Endometriosis Treatment Market Value Share, By Distribution Channel, 2019 (E)
Figure 39: Europe Endometriosis Treatment Market Value Share, By Country, 2019 (E)
Figure 40: Europe Endometriosis Treatment Market Value Analysis (US$ Mn), 2014-2018
Figure 41: Europe Endometriosis Treatment Market Value Forecast (US$ Mn), 2019-2030
Figure 42: Europe Endometriosis Treatment Market Attractiveness Analysis by Drug, 2019-2030
Figure 43: Europe Endometriosis Treatment Market Attractiveness Analysis by Treatment Type, 2019-2030
Figure 44: Europe Endometriosis Treatment Market Attractiveness Analysis by Distribution Channels, 2019-2030
Figure 45: Europe Endometriosis Treatment Market Attractiveness Analysis by Country, 2019-2030
Figure 46: South Asia Endometriosis Treatment Market Value Share, By Drug, 2019 (E)
Figure 47: South Asia Endometriosis Treatment Market Value Share, By Treatment Type, 2019 (E)
Figure 48: South Asia Endometriosis Treatment Market Value Share, By Distribution Channel, 2019 (E)
Figure 49: South Asia Endometriosis Treatment Market Value Share, By Country, 2019 (E)
Figure 50: South Asia Endometriosis Treatment Market Value Analysis (US$ Mn), 2014-2018
Figure 51: South Asia Endometriosis Treatment Market Value Forecast (US$ Mn), 2019-2030
Figure 52: South Asia Endometriosis Treatment Market Attractiveness Analysis by Drug, 2019-2030
Figure 53: South Asia Endometriosis Treatment Market Attractiveness Analysis by Treatment Type, 2019-2030
Figure 54: South Asia Endometriosis Treatment Market Attractiveness Analysis by Distribution Channels, 2019-2030
Figure 55: South Asia Endometriosis Treatment Market Attractiveness Analysis by Country, 2019-2030
Figure 56: East Asia Endometriosis Treatment Market Value Share, By Drug, 2019 (E)
Figure 57: East Asia Endometriosis Treatment Market Value Share, By Treatment Type, 2019 (E)
Figure 58: East Asia Endometriosis Treatment Market Value Share, By Distribution Channel, 2019 (E)
Figure 59: East Asia Endometriosis Treatment Market Value Share, By Country, 2019 (E)
Figure 60: East Asia Endometriosis Treatment Market Value Analysis (US$ Mn), 2014-2018
Figure 61: East Asia Endometriosis Treatment Market Value Forecast (US$ Mn), 2019-2030
Figure 62: East Asia Endometriosis Treatment Market Attractiveness Analysis by Drug, 2019-2030
Figure 63: East Asia Endometriosis Treatment Market Attractiveness Analysis by Treatment Type, 2019-2030
Figure 64: East Asia Endometriosis Treatment Market Attractiveness Analysis by Distribution Channels, 2019-2030
Figure 65: East Asia Endometriosis Treatment Market Attractiveness Analysis by Country, 2019-2030
Figure 66: Oceania Endometriosis Treatment Market Value Share, By Drug, 2019 (E)
Figure 67: Oceania Endometriosis Treatment Market Value Share, By Treatment Type, 2019 (E)
Figure 68: Oceania Endometriosis Treatment Market Value Share, By Distribution Channel, 2019 (E)
Figure 69: Oceania Endometriosis Treatment Market Value Share, By Country, 2019 (E)
Figure 70: Oceania Endometriosis Treatment Market Value Analysis (US$ Mn), 2014-2018
Figure 71: Oceania Endometriosis Treatment Market Value Forecast (US$ Mn), 2019-2030
Figure 72: Oceania Endometriosis Treatment Market Attractiveness Analysis by Drug, 2019-2030
Figure 73: Oceania Endometriosis Treatment Market Attractiveness Analysis by Treatment Type, 2019-2030
Figure 74: Oceania Endometriosis Treatment Market Attractiveness Analysis by Distribution Channels, 2019-2030
Figure 75: Oceania Endometriosis Treatment Market Attractiveness Analysis by Country, 2019-2030
Figure 76: MEA Endometriosis Treatment Market Value Share, By Drug, 2019 (E)
Figure 77: MEA Endometriosis Treatment Market Value Share, By Treatment Type, 2019 (E)
Figure 78: MEA Endometriosis Treatment Market Value Share, By Distribution Channel, 2019 (E)
Figure 79: MEA Endometriosis Treatment Market Value Share, By Country, 2019 (E)
Figure 80: MEA Endometriosis Treatment Market Value Analysis (US$ Mn), 2014-2018
Figure 81: MEA Endometriosis Treatment Market Value Forecast (US$ Mn), 2019-2030
Figure 82: MEA Endometriosis Treatment Market Attractiveness Analysis by Drug, 2019-2030
Figure 83: MEA Endometriosis Treatment Market Attractiveness Analysis by Treatment Type, 2019-2030
Figure 84: MEA Endometriosis Treatment Market Attractiveness Analysis by Distribution Channels, 2019-2030
Figure 85: MEA Endometriosis Treatment Market Attractiveness Analysis by Country, 2019-2030
Figure 86: India Endometriosis Treatment Market Value Analysis (US$ Mn), 2014-2018
Figure 87: India Endometriosis Treatment Market Value Forecast (US$ Mn), 2019-2030
Figure 88: China Endometriosis Treatment Market Value Analysis (US$ Mn), 2014-2018
Figure 89: China Endometriosis Treatment Market Value Forecast (US$ Mn), 2019-2030
Figure 90: Brazil Endometriosis Treatment Market Value Analysis (US$ Mn), 2014-2018
Figure 91: Brazil Endometriosis Treatment Market Value Forecast (US$ Mn), 2019-2030
Figure 92: U. S. Endometriosis Treatment Market Value Analysis (US$ Mn), 2019 & 2030
Figure 93: U. S. Endometriosis Treatment Market Value Share, By Drug, 2019 (E)
Figure 94: U. S. Endometriosis Treatment Market Value Share, By Treatment Type, 2019 (E)
Figure 95: U. S. Endometriosis Treatment Market Value Share, By Distribution Channel, 2019 (E)
Figure 96: Canada Endometriosis Treatment Market Value Analysis (US$ Mn), 2019 & 2030
Figure 97: Canada Endometriosis Treatment Market Value Share, By Drug, 2019 (E)
Figure 98: Canada Endometriosis Treatment Market Value Share, By Treatment Type, 2019 (E)
Figure 99: Canada Endometriosis Treatment Market Value Share, By Distribution Channel, 2019 (E)
Figure 100: Mexico Endometriosis Treatment Market Value Analysis (US$ Mn), 2019 & 2030
Figure 101: Mexico Endometriosis Treatment Market Value Share, By Drug, 2019 (E)
Figure 102: Mexico Endometriosis Treatment Market Value Share, By Treatment Type, 2019 (E)
Figure 103: Mexico Endometriosis Treatment Market Value Share, By Distribution Channel, 2019 (E)
Figure 104: Germany Endometriosis Treatment Market Value Analysis (US$ Mn), 2019 & 2030
Figure 105: Germany Endometriosis Treatment Market Value Share, By Drug, 2019 (E)
Figure 106: Germany Endometriosis Treatment Market Value Share, By Treatment Type, 2019 (E)
Figure 107: Germany Endometriosis Treatment Market Value Share, By Distribution Channel, 2019 (E)
Figure 108: U.K. Endometriosis Treatment Market Value Analysis (US$ Mn), 2019 & 2030
Figure 109: U.K. Endometriosis Treatment Market Value Share, By Drug, 2019 (E)
Figure 110: U.K Endometriosis Treatment Market Value Share, By Treatment Type, 2019 (E)
Figure 111: U.K. Endometriosis Treatment Market Value Share, By Distribution Channel, 2019 (E)
Figure 112: France Endometriosis Treatment Market Value Analysis (US$ Mn), 2019 & 2030
Figure 113: France Endometriosis Treatment Market Value Share, By Drug, 2019 (E)
Figure 114: France Endometriosis Treatment Market Value Share, By Treatment Type, 2019 (E)
Figure 115: France Endometriosis Treatment Market Value Share, By Distribution Channel, 2019 (E)
Figure 116: Italy Endometriosis Treatment Market Value Analysis (US$ Mn), 2019 & 2030
Figure 117: Italy Endometriosis Treatment Market Value Share, By Drug, 2019 (E)
Figure 118: Italy Endometriosis Treatment Market Value Share, By Treatment Type, 2019 (E)
Figure 119: Italy Endometriosis Treatment Market Value Share, By Distribution Channel, 2019 (E)
Figure 120: Spain Endometriosis Treatment Market Value Analysis (US$ Mn), 2019 & 2030
Figure 121: Spain Endometriosis Treatment Market Value Share, By Drug, 2019 (E)
Figure 122: Spain Endometriosis Treatment Market Value Share, By Treatment Type, 2019 (E)
Figure 123: Spain Endometriosis Treatment Market Value Share, By Distribution Channel, 2019 (E)
Figure 124: Russia Endometriosis Treatment Market Value Analysis (US$ Mn), 2019 & 2030
Figure 125: Russia Endometriosis Treatment Market Value Share, By Drug, 2019 (E)
Figure 126: Russia Endometriosis Treatment Market Value Share, By Treatment Type, 2019 (E)
Figure 127: Russia Endometriosis Treatment Market Value Share, By Distribution Channel, 2019 (E)
Figure 128: Japan Endometriosis Treatment Market Value Analysis (US$ Mn), 2019 & 2030
Figure 129: Japan Endometriosis Treatment Market Value Share, By Drug, 2019 (E)
Figure 130: Japan Endometriosis Treatment Market Value Share, By Treatment Type, 2019 (E)
Figure 131: Japan Endometriosis Treatment Market Value Share, By Distribution Channel, 2019 (E)
Figure 132: South Korea Endometriosis Treatment Market Value Analysis (US$ Mn), 2019 & 2030
Figure 133: South Korea Endometriosis Treatment Market Value Share, By Drug, 2019 (E)
Figure 134: South Korea Endometriosis Treatment Market Value Share, By Treatment Type, 2019 (E)
Figure 135: South Korea Endometriosis Treatment Market Value Share, By Distribution Channel, 2019 (E)
Figure 136: Australia Endometriosis Treatment Market Value Analysis (US$ Mn), 2019 & 2030
Figure 137: Australia Endometriosis Treatment Market Value Share, By Drug, 2019 (E)
Figure 138: Australia Endometriosis Treatment Market Value Share, By Treatment Type, 2019 (E)
Figure 139: Australia Endometriosis Treatment Market Value Share, By Distribution Channel, 2019 (E)
Figure 140: New Zealand Endometriosis Treatment Market Value Analysis (US$ Mn), 2019 & 2030
Figure 141: New Zealand Endometriosis Treatment Market Value Share, By Drug, 2019 (E)
Figure 142: New Zealand Endometriosis Treatment Market Value Share, By Treatment Type, 2019 (E)
Figure 143: New Zealand Endometriosis Treatment Market Value Share, By Distribution Channel, 2019 (E)
Figure 144: GCC Countries Endometriosis Treatment Market Value Analysis (US$ Mn), 2019 & 2030
Figure 145: GCC Countries Endometriosis Treatment Market Value Share, By Drug, 2019 (E)
Figure 146: GCC Countries Endometriosis Treatment Market Value Share, By Treatment Type, 2019 (E)
Figure 147: GCC Countries Endometriosis Treatment Market Value Share, By Distribution Channel, 2019 (E)
Figure 148: South Africa Endometriosis Treatment Market Value Analysis (US$ Mn), 2019 & 2030
Figure 149: South Africa Endometriosis Treatment Market Value Share, By Drug, 2019 (E)
Figure 150: South Africa Endometriosis Treatment Market Value Share, By Treatment Type, 2019 (E)
Figure 151: South Africa Endometriosis Treatment Market Value Share, By Distribution Channel, 2019 (E)
Figure 152: Turkey Endometriosis Treatment Market Value Analysis (US$ Mn), 2019 & 2030
Figure 153: Turkey Endometriosis Treatment Market Value Share, By Drug, 2019 (E)
Figure 154: Turkey Endometriosis Treatment Market Value Share, By Treatment Type, 2019 (E)
Figure 155: Turkey Endometriosis Treatment Market Value Share, By Distribution Channel, 2019 (E)
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
